Interferon-gamma: pleiotropic effects on a rat pancreatic beta cell line

Area of Science:

• Immunology
• Endocrinology
• Cell Biology

Background:

• Interferon-gamma (IFN-gamma) upregulates class I major histocompatibility proteins on pancreatic beta cells.
• This suggests IFN-gamma may enhance cytotoxic lymphocyte-mediated beta cell damage in type 1 diabetes.

Purpose of the Study:

• To investigate the effects of IFN-gamma on pancreatic beta cells.
• To define IFN-gamma's impact on major histocompatibility protein expression, (pro)insulin synthesis, protein synthesis, and cell growth using the RIN-m5F insulinoma line.

Main Methods:

• Treatment of RIN-m5F cells with varying concentrations of IFN-gamma.
• Assessment of class I and II major histocompatibility protein expression.
• Measurement of (pro)insulin and protein synthesis rates.
• Evaluation of cell growth and morphology changes.

Main Results:

• IFN-gamma induced a dose-dependent increase in class I major histocompatibility proteins (maximal 10-fold at 1 U/ml).
• Cycloheximide abolished IFN-gamma's induction of class I proteins.
• Class II (Ia) proteins were not detected.
• (Pro)insulin and protein synthesis decreased by 60% and 40% respectively at 10 U/ml IFN-gamma.
• RIN-m5F cell growth was significantly inhibited, with morphological changes observed after 3 days of exposure to 10 U/ml IFN-gamma.

Conclusions:

• IFN-gamma may amplify cytotoxic T cell activity against pancreatic beta cells.
• IFN-gamma can directly inhibit beta cell function and growth.
• These mechanisms may contribute to the pathogenesis of insulin-dependent diabetes.